Dec 4, 2025 · Pegfilgrastim (Neulasta brand and all biosimilars) is used to reduce the risk of infection (febrile neutropenia) in patients with non-myeloid malignancies receiving …

Feb 1, 2025 · Pegfilgrastim helps the bone marrow to make new white blood cells. When certain cancer medicines are used to fight cancer cells, they also affect the white blood cells that fight …

Pegfilgrastim, sold under the brand name Neulasta among others, is a PEGylated form of the recombinant human granulocyte colony-stimulating factor (GCSF) analog filgrastim. [22]

Pegfilgrastim injection products are used to reduce the chance of infection in people who have certain types of cancer and are receiving chemotherapy medications that may decrease the …

Pegfilgrastim is a pegylated granulocyte colony-stimulating factor approved by the FDA to reduce the risk of febrile neutropenia in patients receiving myelosuppressive chemotherapy regimens. …

Pegfilgrastim is a medication that lowers your risk of developing an infection if you receive chemotherapy. It works by helping your body make more white blood cells.

Mar 10, 2025 · Pegfilgrastim is used to prevent infection in people with low levels of white blood cells called neutrophils. It stimulates the bone marrow to make more neutrophils, which help …

Oct 2, 2025 · Neulasta (pegfilgrastim) is a colony-stimulating factor, a man-made form of a protein that stimulates the growth of white blood cells, used to decrease the incidence of infection, by …

This page contains brief information about pegfilgrastim and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

Pegfilgrastim This information from Lexicomp explains what you need to know about this medication, including what it’s used for, how to take it, its side effects, and when to call your …